Insights

Expansion Opportunities BioNTech is expanding its offices in Mainz, Germany by adding 350 jobs while implementing job cuts in other regions. This expansion may present opportunities for sales partnerships with local businesses and suppliers to support the growing workforce and operations.

Vaccine Development With a focus on developing mRNA vaccines for infectious diseases, BioNTech's expertise and pipeline present potential collaboration opportunities for sales of research tools, laboratory equipment, and consumables to support vaccine development efforts.

Financial Health Despite recent headcount adjustments, BioNTech's revenue of over $1 billion signals stability and growth potential. This financial health suggests opportunities for high-value partnerships in areas such as technology, logistics, and specialized services.

Technology Integration Utilizing a tech stack that includes Power BI, Python, and other tools, BioNTech demonstrates a commitment to innovation. Sales professionals can explore opportunities to offer tech solutions, software licensing, or IT services to enhance BioNTech's operations.

Competitive Positioning BioNTech's focus on mRNA technologies and immunotherapies positions it as a key player in the biotechnology industry. Sales representatives can leverage this strong market position to offer complementary products or services to enhance BioNTech's portfolio.

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including Power BI, Babel, AngularJS, and more. Explore BioNTech SE's tech stack below.

  • Power BI
    Business Intelligence
  • Babel
    Development
  • AngularJS
    Javascript Frameworks
  • UNIX
    Operating Systems
  • Python
    Programming Languages
  • Friendly Captcha
    Security
  • Microsoft Exchange
    Storage
  • ProvenExpert
    Widgets

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 1 format(s):
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.deJohn.Doe@biontech.de
92%
FLast@biontech.deJDoe@biontech.de
5%
First.Middle@biontech.deJohn.Michael@biontech.de
1%
LF@biontech.deDJ@biontech.de
2%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

Minus sign iconPlus sign icon
BioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon
You can contact BioNTech SE's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign icon
BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign icon
BioNTech SE's official website is biontech.de and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon
As of April 2025, BioNTech SE's annual revenue reached $18B.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign icon
BioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign icon
As of April 2025, BioNTech SE has approximately 5K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Operating Officer: S. P.Chief Financial Officer: J. H.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign icon
BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign icon
BioNTech SE's tech stack includes Power BIBabelAngularJSUNIXPythonFriendly CaptchaMicrosoft ExchangeProvenExpert.

What is BioNTech SE's email format?

Minus sign iconPlus sign icon
BioNTech SE's email format typically follows the pattern of . Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon
As of April 2025, BioNTech SE has raised $145M in funding. The last funding round occurred on May 29, 2024 for $145M.

When was BioNTech SE founded?

Minus sign iconPlus sign icon
BioNTech SE was founded in 2008.
BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany1001-5000 Employees

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. 

BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.  

BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. 

Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: www.biontech.com/careers 

🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html  
 
🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

Section iconCompany Overview

Headquarters
An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
1001-5000

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.